Self-Management Assistance for Recommended Treatment (SMART) Portal

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

87 participants

Study Classification

OBSERVATIONAL

Study Start Date

2013-07-31

Study Completion Date

2016-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of the study is to develop, evaluate, and optimize an interactive website (the SMART portal). The SMART portal will use IBD-specific and general assessments and interventions to reduce the burden of common barriers to treatment adherence and enhance self-management skills. This study aims to build and revise the SMART portal according to feedback and testing from participants.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

SMART-IBD App Trial

NCT06023667

Inflammatory Bowel Diseases IBD Crohn Disease +1 more

COMPLETED NA

Evaluation of the SMART IBD App in Pediatric IBD

NCT07195123

Inflammatory Bowel Disease (IBD) IBD (Inflammatory Bowel Disease) IBD - Inflammatory Bowel Disease +4 more

RECRUITING NA

IBD Self-management Website and Home Faecal Calprotectin Monitoring

NCT03671980

Inflammatory Bowel Diseases Crohn Disease Ulcerative Colitis +1 more

COMPLETED NA

Medical Treatment Versus Surgery in Stricturing Small Bowel Crohn's Disease

NCT05584228

Crohn Disease

NOT_YET_RECRUITING NA

Improving the Quality of Care for Adults With Inflammatory Bowel Disease

NCT02791854

Crohn's Disease Ulcerative Colitis Inflammatory Bowel Diseases

ENROLLING_BY_INVITATION

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The study consists of three phases for development and evaluation of the SMART portal. Phase 1 is the development of online assessments and intervention components. There will be no participant interaction with the portal during Phase 1. Phase 2 will consist of one, individual interview with patients, caregivers, and clinicians/nurses to interact with a portal prototype and provide feedback. Phase 3 will contain an open trial for patients and caregivers with baseline, 2-6 months interacting with the portal and progressing through applicable intervention components, and post-treatment. Patient test data will also be loaded into the portal during Phase 3 for clinicians/nurses to interact with for 2-6 months. Feedback from all users will be collected at post-treatment for optimization of the portal.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Crohn's Disease Ulcerative Colitis Indeterminate Colitis Inflammatory Bowel Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Clinicians/Nurses

Clinicians and nurses who treat patients diagnosed with IBD will be recruited to interact with and use the SMART portal to provide feedback on optimization.

No interventions assigned to this group

Patients

Patients age 11-18 years diagnosed with IBD will be recruited to interact with and use the SMART portal to provide feedback on optimization.

No interventions assigned to this group

Caregivers

Caregivers of patients diagnosed with IBD will be recruited to interact with and use the SMART portal to provide feedback on optimization.

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patient diagnosed with Crohn's disease, ulcerative colitis, or indeterminate colitis (collectively known as IBD)
* Patient between 11 and 18 years of age
* Patient prescribed at least one oral medication used to treat IBD
* Access to the internet whether public (example, library) or private (example, home, personal)
* English fluency for patient, caregiver, and clinician/nurse
* Clinician/nurse currently providing medical treatment to patients diagnosed with IBD through the IBD Center at Cincinnati Children's Hospital Medical Center

Exclusion Criteria

* Diagnosis of pervasive developmental disorder in patient or caregiver
* Diagnosis of serious mental illness (example, schizophrenia) in patient or caregiver

Minimum Eligible Age

11 Years

Maximum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No